Helpdesk

Sales contact

Home > Resources > Make clinical trials an enjoyable experience: use a small tablet device! #infography

Make clinical trials an enjoyable experience: use a small tablet device! #infography

Last updated: June 24, 2024

A small tablet is the perfect choice between a smartphone and a “classic” tablet. A user-friendly device, it is adapted to both on-site and home use, to specific therapeutic areas and populations.

Discover the full advantages of using a small tablet device in a clinical trial below!

To download “Make clinical trials an enjoyable experience: use a small tablet device!“:

[tag url=”https://kayentis.com/wp-content/uploads/2020/10/use_a_small_tablet_for_an_enjoyable_clinical_trial_experience_infography_kayentis_2020.pdf”]

Learn more:

ePRO and eDiary: What about using a single device?

eCOA training: How to maximize data collection and completeness?

3 reasons for using tablet for clinical data collection @Home

Subscribe to our newsletter

Leveraging the potential of Patient Reported Outcome (PRO) data to...

Gastrointestinal Tract Diseases Research: Moving Towards Patient-Centered Clinical Trials

Turning experience into evidence: PROs in IBD clinical research

BYOD on the rise

Strategies to promote BYOD adoption by clinical study sites

How Kayentis reduces the CO2 emissions of your eCOA projects...

About the author

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.

Meet us at the following events

The critical importance of Patient Reported Outcomes (PROs) for Emerging Biopharma Companies – Webinar

July 9 • 11-12AM EDT / 4-5PM GMT / 5-6PM CET

In today’s competitive landscape, biotech and emerging biopharma companies (EBPs) must demonstrate the value of their innovations early and convincingly....